Xeltis
Transforming standards of care in cardiovascular treatments
Xeltis has raised €177M across 9 funding rounds from 16 investors, most recently a round in Jul 2026. Based in Zurich, Switzerland; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€177M
€176,679,287
Funding rounds
9
Investors
16
distinct backers
Active since
2014-12
latest 2026-07
Funding by year
EUR raised per year · 2026 YTDXeltis — funding by year — interactive chart.
Data table
| Xeltis — funding by year | |
|---|---|
| 2014 | €27M |
| 2017 | €45M |
| 2019 | €11M |
| 2021 | €15M |
| 2022 | €15M |
| 2023 | €45M |
| 2026 | €19M |
Signals
High confidenceRaise-next likelihood18
base rate 30% for Other
- ▼ Raised very recently
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood27
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 9 rounds raised
- ▼ Old (20y) — past typical exit age
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
9 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-28 | Other | €19M | DaVita Venture Group,EQT Life Sciences,European Innovation Council (EIC),Existing Shareholders,Horizon 3 Healthcare,Invest-NL+1 more | View deal → |
| 2023-08-14 | Other | €13M | European Innovation Council (EIC) | View deal → |
| 2023-02-23 | Series D+ | €32M | DaVita Venture Group,EQT Life Sciences,Grand Pharma,international investors,Invest-NL | View deal → |
| 2022-08-09 | Series D+ | €15M | Grand Pharmaceutical Group | View deal → |
| 2021-11-29 | Other | €15M | European Investment Bank (EIB) | View deal → |
| 2019-10-01 | Series D+ | €11M | LSP | View deal → |
| 2017-11-16 | Other | €0 | — | View deal → |
| 2017-04-01 | Series C | €45M | Ysios Capital | View deal → |
| 2014-12-01 | Series B | €27M | Life Sciences Partners,VI Partners | View deal → |
Investors
16Related news
- Medtech startup secures €32 million in series D2 roundstartupticker.ch · 2023-02
- Chinese pharma giant backs Dutch medtech Xeltis with €15 milliontech.eu · 2022-08
- Dutch-Swiss medtech firm Xeltis lands €15M from EIB for its restorative approach in cardiovascular therapysiliconcanals.com · 2021-11
- eustartups.news
- tech.eu
- tech.eu
- eu-startups.com
- xeltis.com
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData